{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T20:09:20Z","timestamp":1786738160235,"version":"build-2736575974"},"reference-count":70,"publisher":"American Chemical Society (ACS)","issue":"11","license":[{"start":{"date-parts":[[2021,3,9]],"date-time":"2021-03-09T00:00:00Z","timestamp":1615248000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,3,23]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>COVID-19 is a deadly pandemic and has resulted in a huge loss of money and life in the past few months. It is well known that the SARS-CoV-2 gene mutates relatively slowly as compared to other viruses but still may create hurdles in developing vaccines. Therefore, there is a need to develop alternative routes for its management and treatment of COVID-19. Based on the severity of viral infection in COVID-19 patients, critically ill patients (\u223c5%, with old age, and comorbidities) are at high risk of morbidities. The reason for this severity in such patients is attributed to \u201cmisleading cytokine storm\u201d, which produces ARDS and results in the deaths of critically ill patients. In this connection, ethyl pyruvate (EP) controls these cytokines\/chemokines, is an anti-inflammatory agent, and possesses a protective effect on the lungs, brain, heart, and mitochondria against various injuries. Considering these facts, we propose that the site-selective EP formulations (especially aerosols) could be the ultimate adjuvant therapy for the regulation of misleading cytokine storm in severely affected COVID-19 patients and could reduce the mortalities.<\/jats:p>","DOI":"10.1021\/acsomega.1c00157","type":"journal-article","created":{"date-parts":[[2021,3,9]],"date-time":"2021-03-09T13:32:30Z","timestamp":1615296750000},"page":"7754-7760","source":"Crossref","is-referenced-by-count":7,"title":["Ethyl Pyruvate as a Potential Defense Intervention\nagainst Cytokine Storm in COVID-19?"],"prefix":"10.1021","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2832-0044","authenticated-orcid":true,"given":"Omprakash","family":"Tanwar","sequence":"first","affiliation":[{"name":"Shri G.S. Institute of Technology and Science , , 23, Sir M. Visvesvaraya Marg (Park Road) , , ,","place":["Indore, Madhya Pradesh, India, 452003"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aastha","family":"Soni","sequence":"additional","affiliation":[{"name":"Shri G.S. Institute of Technology and Science , , 23, Sir M. Visvesvaraya Marg (Park Road) , , ,","place":["Indore, Madhya Pradesh, India, 452003"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pawan","family":"Prajapat","sequence":"additional","affiliation":[{"name":"Shri G.S. Institute of Technology and Science , , 23, Sir M. Visvesvaraya Marg (Park Road) , , ,","place":["Indore, Madhya Pradesh, India, 452003"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanu","family":"Shivhare","sequence":"additional","affiliation":[{"name":"Shri G.S. Institute of Technology and Science , , 23, Sir M. Visvesvaraya Marg (Park Road) , , ,","place":["Indore, Madhya Pradesh, India, 452003"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pooja","family":"Pandey","sequence":"additional","affiliation":[{"name":"Shri G.S. Institute of Technology and Science , , 23, Sir M. Visvesvaraya Marg (Park Road) , , ,","place":["Indore, Madhya Pradesh, India, 452003"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Puneet Kumar","family":"Samaiya","sequence":"additional","affiliation":[{"name":"Shri G.S. Institute of Technology and Science , , 23, Sir M. Visvesvaraya Marg (Park Road) , , ,","place":["Indore, Madhya Pradesh, India, 452003"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharad Prakash","family":"Pandey","sequence":"additional","affiliation":[{"name":"Shri G.S. Institute of Technology and Science , , 23, Sir M. Visvesvaraya Marg (Park Road) , , ,","place":["Indore, Madhya Pradesh, India, 452003"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8451-9739","authenticated-orcid":true,"given":"Parimal","family":"Kar","sequence":"additional","affiliation":[{"name":"Indian Institute of Technology , , Khandwa Road, Simrol , , ,","place":["Indore, Madhya Pradesh, India, 453552"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2021,3,9]]},"reference":[{"key":"2026081415082840100_cit1","unstructured":"WHO Coronavirus disease\n(COVID-19) pandemic. https:\/\/www.who.int\/emergencies\/diseases\/novel-coronavirus-2019 (accessed 30 August 2020)."},{"key":"2026081415082840100_cit2","unstructured":"WHO\n          \n          WHO Coronavirus Disease (COVID-19) Dashboard. https:\/\/covid19.who.int\/ (accessed 01 February 2021)."},{"key":"2026081415082840100_cit3","doi-asserted-by":"publisher","first-page":"2684","DOI":"10.1056\/nejmcibr2032888","article-title":"Emergence\nof a Highly Fit SARS-CoV-2 Variant","volume":"383","author":"Baric","year":"2020","journal-title":"N. Engl.\nJ. Med."},{"key":"2026081415082840100_cit4","unstructured":"Callaway, E.\n          \n          The coronavirus\nis mutating \ue5f8 does it matter?\n          https:\/\/www.nature.com\/articles\/d41586-020-02544-6 (accessed 02 February 2021)."},{"key":"2026081415082840100_cit5","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1007\/s10067-020-05190-5","article-title":"Cytokine storm in COVID-19:\npathogenesis and overview of anti-inflammatory agents used in treatment","volume":"39","author":"Soy","year":"2020","journal-title":"Front. Immunol."},{"key":"2026081415082840100_cit6","unstructured":"WHO Clinical\nmanagement of COVID-19. who.int\/publications\/i\/item\/clinical-management-of-covid-19 (accessed 08 September 2020)."},{"key":"2026081415082840100_cit7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2174\/2666796701999200721003212","article-title":"SARS-CoV-2 Therapy: Old Drugs as New Interventions","volume":"1","author":"Samaiya","year":"2020","journal-title":"Coronaviruses"},{"key":"2026081415082840100_cit8","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.jpha.2020.03.001","article-title":"Molecular\nimmune pathogenesis and diagnosis of COVID-19","volume":"10","author":"Li","year":"2020","journal-title":"J. Pharm. Anal."},{"key":"2026081415082840100_cit9","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.3389\/fimmu.2020.01708","article-title":"Cytokine Storm\nin COVID-19: The Current Evidence and Treatment Strategies","volume":"11","author":"Tang","year":"2020","journal-title":"Front. Immunol."},{"key":"2026081415082840100_cit10","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.3389\/fphar.2020.01169","article-title":"Cellular\nand Molecular Pathways of COVID-19 and Potential Points of Therapeutic\nIntervention","volume":"11","author":"Hussman","year":"2020","journal-title":"Front. Pharmacol."},{"key":"2026081415082840100_cit11","unstructured":"WHO Corticosteroids for COVID-19. https:\/\/www.who.int\/publications\/i\/item\/WHO-2019-nCoV-Corticosteroids-2020.1 (accessed 01 February 2021)."},{"key":"2026081415082840100_cit12","doi-asserted-by":"crossref","first-page":"337","DOI":"10.55563\/clinexprheumatol\/xcdary","article-title":"COVID-19, cytokines\nand immunosuppression: what can we learn from severe acute respiratory\nsyndrome?","volume":"38","author":"Sarzi-Puttini","year":"2020","journal-title":"Clin. Exp. Rheumatol."},{"key":"2026081415082840100_cit13","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/s0140-6736(20)30183-5","article-title":"Clinical features of patients infected\nwith 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"The Lancet"},{"key":"2026081415082840100_cit14","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1002\/jmv.26232","article-title":"The cytokine\nstorm and COVID-19","volume":"93","author":"Hu","year":"2020","journal-title":"J. Med. Virol."},{"key":"2026081415082840100_cit15","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.cca.2020.06.017","article-title":"Cytokine storm induced\nby SARS-CoV-2","volume":"509","author":"Song","year":"2020","journal-title":"Clin. Chim. Acta"},{"key":"2026081415082840100_cit16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.virusres.2007.02.007","article-title":"Up-regulation of IL-6\nand TNF-alpha induced by SARS-coronavirus spike\nprotein in murine macrophages via NF-kappaB pathway","volume":"128","author":"Wang","year":"2007","journal-title":"Virus Res."},{"key":"2026081415082840100_cit17","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1111\/tri.13611","article-title":"Why the immune system\nfails to mount an adaptive immune\nresponse to a COVID-19 infection","volume":"33","author":"Ahmadpoor","year":"2020","journal-title":"Transpl. Int."},{"key":"2026081415082840100_cit18","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1093\/rheumatology\/kei282","article-title":"Chloroquine inhibits\nproduction of TNF-\u03b1, IL-1\u03b2 and IL-6 from lipopolysaccharide-stimulated\nhuman monocytes\/macrophages by different modes","volume":"45","author":"Jang","year":"2006","journal-title":"Rheumatology"},{"key":"2026081415082840100_cit19","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.1093\/cid\/ciaa546","article-title":"Chloroquine\nInhibits the Release of Inflammatory Cytokines by Human Lung Explants","volume":"71","author":"Grassin-Delyle","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"2026081415082840100_cit20","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.cytogfr.2020.05.009","article-title":"IL-6: Relevance\nfor immunopathology of SARS-CoV-2","volume":"53","author":"Gubernatorova","year":"2020","journal-title":"Cytokine\nGrowth Factor Rev."},{"key":"2026081415082840100_cit21","unstructured":"Tocilizumab vs CRRT in Management of Cytokine\nRelease Syndrome (CRS)\nin COVID-19 (TACOS). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04306705 (accessed 28 August 2020)."},{"key":"2026081415082840100_cit22","unstructured":"Anti-il6 Treatment\nof Serious COVID-19 Disease With Threatening Respiratory\nFailure (TOCIVID). https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT04322773 (accessed 28 August 2020)."},{"key":"2026081415082840100_cit23","doi-asserted-by":"publisher","first-page":"m2935","DOI":"10.1136\/bmj.m2935","article-title":"Intensive\nimmunosuppression reduces deaths in covid-19-associated cytokine storm\nsyndrome, study finds","volume":"370","author":"Mayor","year":"2020","journal-title":"Br. Med. J."},{"key":"2026081415082840100_cit24","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s10020-020-00172-4","article-title":"Extracellular HMGB1: a therapeutic\ntarget in severe pulmonary inflammation including COVID-19?","volume":"26","author":"Andersson","year":"2020","journal-title":"Mol. Med."},{"key":"2026081415082840100_cit25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1008536","article-title":"The hallmarks\nof COVID-19 disease","volume":"16","author":"Tang","year":"2020","journal-title":"PLoS Pathog."},{"key":"2026081415082840100_cit26","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1084\/jem.192.4.565","article-title":"High mobility group\n1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in\nhuman monocytes","volume":"192","author":"Andersson","year":"2000","journal-title":"J. Exp. Med."},{"key":"2026081415082840100_cit27","doi-asserted-by":"publisher","first-page":"456305","DOI":"10.1155\/2015\/456305","article-title":"Novel Mechanisms of\nHerbal Therapies for Inhibiting\nHMGB1 Secretion or Action","volume":"2015","author":"Wu","year":"2015","journal-title":"J. Evidence-Based\nComplementary Altern. Med."},{"key":"2026081415082840100_cit28","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.bcp.2013.05.013","article-title":"Chloroquine\ninhibits HMGB1 inflammatory\nsignaling and protects mice from lethal sepsis","volume":"86","author":"Yang","year":"2013","journal-title":"Biochem. Pharmacol."},{"key":"2026081415082840100_cit29","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1016\/j.ajem.2020.07.030","article-title":"Acute chloroquine and hydroxychloroquine\ntoxicity: A review for emergency clinicians","volume":"38","author":"Della\nPorta","year":"2020","journal-title":"Am. J. Emerg. Med."},{"key":"2026081415082840100_cit30","doi-asserted-by":"publisher","first-page":"4609","DOI":"10.3390\/ijms21134609","article-title":"HMGB1-Mediated\nNeuroinflammatory Responses in Brain Injuries: Potential Mechanisms\nand Therapeutic Opportunities","volume":"21","author":"Paudel","year":"2020","journal-title":"Int. J. Mol.\nSci."},{"key":"2026081415082840100_cit31","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1126\/science.1171583","article-title":"Benzothiazinones kill Mycobacterium tuberculosis by\nblocking arabinan synthesis","volume":"324","author":"Makarov","year":"2009","journal-title":"Science (New York,\nN.Y.)"},{"key":"2026081415082840100_cit32","doi-asserted-by":"publisher","first-page":"3104","DOI":"10.1093\/brain\/awaa240","article-title":"The emerging spectrum of COVID-19\nneurology: clinical, radiological and laboratory findings","volume":"143","author":"Paterson","year":"2020","journal-title":"Brain"},{"key":"2026081415082840100_cit33","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.cell.2020.10.028","article-title":"Genome-wide\nCRISPR Screens Reveal\nHost Factors Critical for SARS-CoV-2 Infection","volume":"184","author":"Wei","year":"2021","journal-title":"Cell"},{"key":"2026081415082840100_cit34","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.mehy.2004.01.037","article-title":"Pathogenic\nrole of HMGB1 in SARS?","volume":"63","author":"Chen","year":"2004","journal-title":"Med. Hypotheses"},{"key":"2026081415082840100_cit35","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2020.e05672","article-title":"HMGB1 as a potential biomarker and\ntherapeutic target for severe\nCOVID-19","volume":"6","author":"Chen","year":"2020","journal-title":"Heliyon"},{"key":"2026081415082840100_cit36","doi-asserted-by":"publisher","first-page":"7527953","DOI":"10.1155\/2020\/7527953","article-title":"Neutrophil Extracellular\nTraps (NETs) and Damage-Associated Molecular Patterns (DAMPs): Two\nPotential Targets for COVID-19 Treatment","volume":"2020","author":"Cicco","year":"2020","journal-title":"Mediat.\nInflamm."},{"key":"2026081415082840100_cit37","doi-asserted-by":"publisher","first-page":"587","DOI":"10.2174\/1386207323999200728114927","article-title":"Could Targeting\nHMGB1 be useful for\nthe Clinical Management of COVID-19 Infection?","volume":"24","author":"C\u0327elebier","year":"2020","journal-title":"Comb. Chem. High Throughput Screening"},{"key":"2026081415082840100_cit38","unstructured":"Drug Bank: Ethyl pyruvate. https:\/\/www.drugbank.ca\/drugs\/DB05869 (accessed 28 August 2020)."},{"key":"2026081415082840100_cit39","unstructured":"Metabocard for Ethyl\npyruvate (HMDB0031643). https:\/\/hmdb.ca\/metabolites\/HMDB0031643 (accessed 11 September 2020)."},{"key":"2026081415082840100_cit40","unstructured":"Metabocard\nfor Ethyl pyruvate (HMDB0031643). https:\/\/hmdb.ca\/metabolites\/HMDB0031643 (accessed 28 August 2020)."},{"key":"2026081415082840100_cit41","unstructured":"Ethyl pyruvate. https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Ethyl-pyruvate (accessed\n28 August 2020)."},{"key":"2026081415082840100_cit42","volume-title":"Dictionary of food compounds\nwith CD-ROM: additives, flavors, and\ningredients","author":"Shmuel","year":"2004"},{"key":"2026081415082840100_cit43","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1111\/j.1365-2796.2007.01789.x","article-title":"Ethyl pyruvate:\na novel anti-inflammatory agent","volume":"261","author":"Fink","year":"2007","journal-title":"J. Intern.\nMed."},{"key":"2026081415082840100_cit44","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/1465-9921-10-91","article-title":"Ethyl pyruvate\nreduces mortality\nin an endotoxin-induced severe acute lung injury mouse model","volume":"10","author":"Shang","year":"2009","journal-title":"Respir. Res."},{"key":"2026081415082840100_cit45","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.3892\/mmr.2017.6118","article-title":"Protective\neffects of ethyl pyruvate\non lipopolysaccharide-induced acute lung injury through inhibition\nof autophagy in neutrophils","volume":"15","author":"Zhu","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"2026081415082840100_cit46","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s12931-019-0992-3","article-title":"Ethyl pyruvate\nreduces organic dust-induced airway inflammation by targeting HMGB1-RAGE\nsignaling","volume":"20","author":"Bhat","year":"2019","journal-title":"Respir. Res."},{"key":"2026081415082840100_cit47","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.biopha.2017.05.111","article-title":"Ethyl pyruvate alleviates radiation-induced\nlung injury in mice","volume":"92","author":"Chen","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"2026081415082840100_cit48","doi-asserted-by":"publisher","first-page":"331","DOI":"10.2463\/mrms.mp.2017-0163","article-title":"Ethyl Pyruvate\nImproves Pulmonary Function in Mice with Bleomycin-induced Lung Injury\nas Monitored with Hyperpolarized (129)Xe MR Imaging","volume":"17","author":"Hodono","year":"2018","journal-title":"Magn. Reson. Med. Sci."},{"key":"2026081415082840100_cit49","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1002\/mrm.26458","article-title":"Treatment response\nof ethyl pyruvate in a mouse model of chronic obstructive pulmonary\ndisease studied by hyperpolarized (129) Xe MRI","volume":"78","author":"Kimura","year":"2017","journal-title":"Magn Reson Med"},{"key":"2026081415082840100_cit50","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.jss.2007.03.067","article-title":"Ethyl pyruvate\ninhibits\nhypoxic pulmonary vasoconstriction and attenuates pulmonary artery\ncytokine expression","volume":"145","author":"Tsai","year":"2008","journal-title":"J. Surg. Res."},{"key":"2026081415082840100_cit51","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s12640-009-9075-4","article-title":"Combination\nTreatment with Ethyl\nPyruvate and Aspirin Enhances Neuroprotection in the Postischemic\nBrain","volume":"17","author":"Kim","year":"2010","journal-title":"Neurotoxic. Res."},{"key":"2026081415082840100_cit52","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.1007\/s11064-019-02830-4","article-title":"Inhibition\nof Neuronal Nitric Oxide\nSynthase by Ethyl Pyruvate in Schwann Cells Protects Against Peripheral\nNerve Degeneration","volume":"44","author":"Chung","year":"2019","journal-title":"Neurochem. Res."},{"key":"2026081415082840100_cit53","doi-asserted-by":"publisher","first-page":"807142","DOI":"10.1155\/2011\/807142","article-title":"Beneficial\neffects of ethyl pyruvate through inhibiting high-mobility group box\n1 expression and TLR4\/NF-\u03baB pathway after traumatic brain injury\nin the rat","volume":"2011","author":"Su","year":"2011","journal-title":"Mediat. Inflamm."},{"key":"2026081415082840100_cit54","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1111\/j.1476-5381.2011.01804.x","article-title":"Ethyl pyruvate promotes spinal cord\nrepair by ameliorating the glial microenvironment","volume":"166","author":"Yuan","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"2026081415082840100_cit55","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1097\/shk.0b013e31818d4073","article-title":"Beneficial\neffects of ethyl pyruvate in a mouse model of spinal cord injury","volume":"32","author":"Genovese","year":"2009","journal-title":"Shock"},{"key":"2026081415082840100_cit56","doi-asserted-by":"publisher","first-page":"4264580","DOI":"10.1155\/2019\/4264580","article-title":"Protective Effect\nof Ethyl Pyruvate against Myocardial\nIschemia Reperfusion Injury through Regulations of ROS-Related NLRP3\nInflammasome Activation","volume":"2019","author":"Jun","year":"2019","journal-title":"Oxid. Med. Cell. Longevity"},{"key":"2026081415082840100_cit57","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.3892\/etm.2014.1581","article-title":"Effects of ethyl pyruvate on cardiac\nfunction recovery and apoptosis reduction after global cold ischemia\nand reperfusion","volume":"7","author":"Guo","year":"2014","journal-title":"Exp. Ther. Med."},{"key":"2026081415082840100_cit58","doi-asserted-by":"publisher","first-page":"C258","DOI":"10.1152\/ajpcell.00224.2020","article-title":"Decoding SARS-CoV-2\nhijacking of host mitochondria in COVID-19 pathogenesis","volume":"319","author":"Singh","year":"2020","journal-title":"Am. J. Physiol.: Cell Physiol."},{"key":"2026081415082840100_cit59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mito.2020.06.008","article-title":"Mitochondria\nand microbiota\ndysfunction in COVID-19 pathogenesis","volume":"54","author":"Saleh","year":"2020","journal-title":"Mitochondrion"},{"key":"2026081415082840100_cit60","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s10020-018-0006-9","article-title":"Identification\nof ethyl pyruvate as a NLRP3 inflammasome inhibitor that preserves\nmitochondrial integrity","volume":"24","author":"Li","year":"2018","journal-title":"Mol. Med."},{"key":"2026081415082840100_cit61","doi-asserted-by":"publisher","first-page":"157","DOI":"10.3389\/fimmu.2019.00157","article-title":"Ethyl Pyruvate Induces Tolerogenic\nDendritic Cells","volume":"10","author":"Djedovic","year":"2019","journal-title":"Front. Immunol."},{"key":"2026081415082840100_cit62","doi-asserted-by":"publisher","first-page":"30","DOI":"10.3389\/fimmu.2019.00030","article-title":"Ethyl Pyruvate Modulates\nMurine Dendritic Cell Activation\nand Survival Through Their Immunometabolism","volume":"10","author":"Chakhtoura","year":"2019","journal-title":"Front. Immunol."},{"key":"2026081415082840100_cit63","doi-asserted-by":"publisher","first-page":"3130","DOI":"10.3389\/fimmu.2018.03130","article-title":"Ethyl Pyruvate\nStimulates Regulatory\nT Cells and Ameliorates Type 1 Diabetes Development in Mice","volume":"9","author":"Koprivica","year":"2019","journal-title":"Front. Immunol."},{"key":"2026081415082840100_cit64","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0192171","article-title":"Ethyl pyruvate ameliorates\nhepatic\ninjury following blunt chest trauma and hemorrhagic shock by reducing\nlocal inflammation, NF-kappaB activation and HMGB1 release","volume":"13","author":"Wagner","year":"2018","journal-title":"PloS One"},{"key":"2026081415082840100_cit65","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1023\/a:1007055503748","article-title":"Attenuation of sugar\ncataract by ethyl pyruvate","volume":"200","author":"Devamanoharan","year":"1999","journal-title":"Mol. Cell. Biochem."},{"key":"2026081415082840100_cit66","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1159\/000089275","article-title":"Oxidative damage to\nlens in culture:\nreversibility by pyruvate and ethyl pyruvate","volume":"220","author":"Varma","year":"2006","journal-title":"Ophthalmologica"},{"key":"2026081415082840100_cit67","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1097\/01.shk.0000092697.10326.8b","article-title":"Ethyl pyruvate\nprovides durable protection against inflammation-induced intestinal\nepithelial barrier dysfunction","volume":"20","author":"Sappington","year":"2003","journal-title":"Shock (Augusta,\nGa.)"},{"key":"2026081415082840100_cit68","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.jss.2007.02.050","article-title":"The effect of ethyl\npyruvate on oxidative stress in intestine and bacterial translocation\nafter thermal injury","volume":"144","author":"Karabeyog\u0306lu","year":"2008","journal-title":"J. Surg. Res."},{"key":"2026081415082840100_cit69","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1124\/jpet.102.043182","article-title":"Ethyl Pyruvate Ameliorates\nIntestinal Epithelial Barrier Dysfunction in Endotoxemic Mice and\nImmunostimulated Caco-2 Enterocytic Monolayers","volume":"304","author":"Sappington","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"2026081415082840100_cit70","doi-asserted-by":"publisher","first-page":"4058280","DOI":"10.1155\/2019\/4058280","article-title":"Ethyl Pyruvate Prevents\nRenal Damage Induced by Methylglyoxal-Derived Advanced Glycation End\nProducts","volume":"2019","author":"Jung","year":"2019","journal-title":"J. Diabetes Res."}],"container-title":["ACS Omega"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acsomega.1c00157","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/acsodf\/article-pdf\/6\/11\/7754\/3729185\/ao1c00157.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/acsodf\/article-pdf\/6\/11\/7754\/3729185\/ao1c00157.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T19:10:07Z","timestamp":1786734607000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/acsodf\/article\/6\/11\/7754\/384715\/Ethyl-Pyruvate-as-a-Potential-Defense-Intervention"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,9]]},"references-count":70,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2021,3,9]]},"published-print":{"date-parts":[[2021,3,23]]}},"URL":"https:\/\/doi.org\/10.1021\/acsomega.1c00157","relation":{},"ISSN":["2470-1343"],"issn-type":[{"value":"2470-1343","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,9]]}}}